Irati Beltrán Hernández

DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing

Patrick Engelberts, Ida H. Hiemstra, Bart de Jong et al. · EBioMedicine · 2020 · 168 citations · Full text

Life Sciences, Immunology, Oncology +15

Patient-Derived Head and Neck Cancer Organoids Recapitulate EGFR Expression Levels of Respective Tissues and Are Responsive to EGFR-Targeted Photodynamic Therapy

Else Driehuis, Sacha Spelier, Irati Beltrán Hernández et al. · Journal of Clinical Medicine · 2019 · 103 citations · Full text

Medicine, Cancer Biology, Oncology +16

Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session

Marion M. Deken, Marta M. Kijanka, Irati Beltrán Hernández et al. · Journal of Controlled Release · 2020 · 75 citations · Full text

Medicine, Oncology, Pharmacology +17

EGFR-Targeted Nanobody Functionalized Polymeric Micelles Loaded with mTHPC for Selective Photodynamic Therapy

Yanna Liu, Luca Scrivano, Julia D. Peterson et al. · Molecular Pharmaceutics · 2020 · 61 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Imaging of Tumor Spheroids, Dual-Isotope SPECT, and Autoradiographic Analysis to Assess the Tumor Uptake and Distribution of Different Nanobodies

Irati Beltrán Hernández, Rene Rompen, Raffaella Rossin et al. · Molecular Imaging and Biology · 2019 · 34 citations · Full text

Medicine, Nuclear Medicine, Oncology +17